Dataset Information


Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival.

ABSTRACT: Although remission rates for metastatic melanoma are generally very poor, some patients can survive for prolonged periods following metastasis. We used gene expression profiling, mitotic index (MI), and quantification of tumor infiltrating leukocytes (TILs) and CD3+ cells in metastatic lesions to search for a molecular basis for this observation and to develop improved methods for predicting patient survival. We identified a group of 266 genes associated with postrecurrence survival. Genes positively associated with survival were predominantly immune response related (e.g., ICOS, CD3d, ZAP70, TRAT1, TARP, GZMK, LCK, CD2, CXCL13, CCL19, CCR7, VCAM1) while genes negatively associated with survival were cell proliferation related (e.g., PDE4D, CDK2, GREF1, NUSAP1, SPC24). Identification of genes associated with survival of metastatic melanoma Overall design: Survival Analysis was performed using Statistical Analysis of Microarrays B D denotes same patient with multiple reccurences


INSTRUMENT(S): [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array

ORGANISM(S): Homo sapiens  

SUBMITTER: Dusan Bogunovic  

PROVIDER: GSE19234 | GEO | 2009-12-01



Similar Datasets

2009-11-30 | E-GEOD-19234 | ArrayExpress
2013-09-30 | E-GEOD-33115 | ArrayExpress
2013-02-01 | E-GEOD-37259 | ArrayExpress
| GSE98023 | GEO
| GSE37259 | GEO
2010-12-14 | E-GEOD-22138 | ArrayExpress
2010-12-14 | GSE22138 | GEO
2012-06-07 | E-GEOD-15605 | ArrayExpress
2015-01-08 | ST000133 | MetabolomicsWorkbench
2012-06-08 | GSE15605 | GEO